There is no single number. A gynae PCD franchise in India can start anywhere from a modest first order to several lakh, and the honest answer is that it depends on your district, your opening range and whether you already hold a drug licence. What follows is where the money actually goes, so you can build your own figure instead of trusting someone else’s.
Table of Contents
ToggleA wholesale drug licence (Forms 20B and 21B) carries a government fee that is modest in itself. The real cost sits around it: premises that meet the prescribed area requirement, a refrigerator, and a competent person — a registered pharmacist, or a graduate with a year of drug-trade experience. If you are not that person yourself, that is a salary.
GST registration is free. PAN, if you do not already have one for the business, is negligible. See the documents required for the full list.
You need a space used exclusively for the drug business, meeting your state’s minimum area. In a tier-3 district this can be a rented room. In a metro it is the largest fixed cost in the whole exercise. Rent varies so widely across India that any national average is meaningless — price your own.
This is the number people mean when they ask about investment, and it is the most controllable. It scales with how many products you carry, not with the size of your ambition.
A partner starting with one or two therapeutic series relevant to the doctors they already call on will place a far smaller opening order than someone trying to stock a whole 200-product portfolio on day one. The second approach is almost always a mistake. You tie up capital in products you have no prescriber for, and a meaningful share of it expires on your shelf.
Opening stock is a one-off. Working capital is forever, and it is what actually kills undercapitalised distributors.
The cycle runs like this. You pay the company in advance. Stock arrives. You supply chemists, often on credit of 30 to 60 days. Meanwhile you need to reorder to stay in stock, because a distributor who runs out in month three hands the prescription to a competitor permanently.
So for a period you are funding two cycles at once — the stock sitting with chemists unpaid, and the stock you need on your own shelf. Budget for that gap explicitly. Distributors who plan only for the opening order discover this in month two.
Promotional input. Visual-aid folders, product card manuals, MR bags, order books, samples and reminder cards are normally supplied free against your order, as per demand. A company charging separately for its own marketing material is worth a second look.
Neither should you be paying a “franchise fee”, a “registration fee” or a refundable security deposit in most PCD arrangements. The company’s return comes from selling you stock. If a large upfront payment is required before any product moves, ask precisely what it buys.
It varies with your district, premises cost, whether you already hold a drug licence, and how many products you start with. The controllable part is the opening stock, and most partners begin with one or two therapeutic series rather than a full portfolio. Ask the company to size an opening order against the doctors you can actually reach.
Usually not. In a standard PCD arrangement the company earns from supplying stock, not from an upfront fee. If a significant payment is demanded before any product moves, ask specifically what it covers.
Commonly yes. Most PCD supply is invoiced ex-factory against advance payment with dispatch on receipt. Meanwhile you may be extending credit to chemists, so plan working capital for both cycles running at once.
It should not be. Visual aids, product card manuals, samples, order books and reminder cards are normally supplied free against your order as per demand.
Many do, particularly medical representatives moving into distribution who already know the prescribers. The constraint is not time at the start — it is the drug licence, the premises and the working capital, all of which are required whether you work full-time or not.
Halefem Gynae markets 200+ gynae formulations across six therapeutic series to franchise partners across India, one partner per district. Tell us your district and which doctors you call on, and we will suggest an opening order that reflects what you can actually sell — not the largest one we could invoice.
Call +91-9888020547, or read about the gynae PCD pharma franchise, monopoly rights and partner support. Price list on request — trade terms are partner-specific and we do not publish them.
Halefem Gynae — a gynae division of Edmund Healthcare Pvt. Ltd., an ISO 9001:2015 certified company. Products manufactured at WHO-GMP compliant units, Sai Road, Baddi, Himachal Pradesh.
General commercial information for distributors in India. Costs vary by state and change over time; this is not financial advice.